Literature DB >> 18154536

Control of infections due to extended-spectrum beta-lactamase-producing organisms in hospitals and the community.

R E Warren1, G Harvey, R Carr, D Ward, A Doroshenko.   

Abstract

Control of infection classically involves hand and healthcare hygiene, reduction of selective and ineffective chemotherapy, reduction of invasive procedures and achlorhydria and adequate staffing, along with appropriate containment and concentration of patients. Investigation and control of any continuing sources of infection in food and water supplies is important also, as is recognition of individuals carrying high-risk strains and species. The onset of infection may be distant from the time of acquisition and may critically affect epidemiological assessment of control points. Carriage may be prolonged, increasing the likelihood of recurrent infection and exacerbating the difficulty of control. Mortality associated with resistance is difficult to assess retrospectively and may not be high, complicating analysis of the success or failure of control measures.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18154536     DOI: 10.1111/j.1469-0691.2007.01870.x

Source DB:  PubMed          Journal:  Clin Microbiol Infect        ISSN: 1198-743X            Impact factor:   8.067


  3 in total

1.  Colorimetric-plate method for rapid disk diffusion susceptibility testing of Escherichia coli.

Authors:  Sehnaz Sener; Ibrahim Cagatay Acuner; Yuksel Bek; Belma Durupinar
Journal:  J Clin Microbiol       Date:  2011-01-19       Impact factor: 5.948

2.  Rapid typing of extended-spectrum β-lactamase- and carbapenemase-producing Escherichia coli and Klebsiella pneumoniae isolates by use of SpectraCell RA.

Authors:  Diana Willemse-Erix; Tom Bakker-Schut; Femke Slagboom-Bax; Jan-willem Jachtenberg; Nicole Lemmens-den Toom; Costas C Papagiannitsis; Kuntaman Kuntaman; Gerwin Puppels; Alex van Belkum; Juliëtte A Severin; Wil Goessens; Kees Maquelin
Journal:  J Clin Microbiol       Date:  2012-01-11       Impact factor: 5.948

3.  ESBLs: A Clear and Present Danger?

Authors:  Rishi H-P Dhillon; John Clark
Journal:  Crit Care Res Pract       Date:  2011-06-06
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.